Skip to content
Saleshttps://cannpal.com
+61(2)61083622 Ph: +61 (2) 6108 3622
CannPalCannPal Animal Healthinfo@cannpal.com+61(2)6108362249https://cannpal.com
CannPal Logo
Home About Contact Resource Centre

Resource Centre

Educational resources to assist veterinarians and pet owners in cannabinoid derived therapeutics.

Resource Centre

  • Publications
    Read More
  • Videos
    Read More
  • Regulations
    Read More
  • Veterinary News
    Read More
  • Useful Links
    Read More

Publications

  • Original Papers
    Read More
  • Reviews
    Read More
  • Animal Research
    Read More

Original Papers

27th Annual Symposium of the International Cannabinoid Research Society, Montreal, Canada

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis

Endocannabinoids in arthritis: current views and perspective

The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study

Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy?

  • SUBSCRIBE

  • This field is for validation purposes and should be left unchanged.

Invest in CannPal

CannPal Animal Therapeutics Limited (“CannPal”) is a pharmaceutical-focused animal health company researching the benefits of medical cannabis for companion animals. The company is listed on the Australian Stock Exchange (ASX) in 2017, trading under the ASX ticker “CP1”. CannPal was founded to research, develop and commercialise, regulatory approved medicines derived from the medical cannabis plant to provide veterinarians with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.

Learn More

CannPal Logo
info@cannpal.com +61 (2) 6108 3622 Privacy Policy
Copyright © CannPal 2024. All rights reserved. Designed and Developed by Web Bird Digital

Sorry to interrupt

Want to be the first to know about the latest developments in the animal cannabinoid therapeutics industry?

Sign up to our monthly newsletter to keep up-to-date!

  • SUBSCRIBE

  • This field is for validation purposes and should be left unchanged.

View our Privacy Policy